The epigenetic medicine company anchors its Peninsula headquarters as the Bay Area life sciences market navigates a gradual recovery. Epicrispr Biotechnologies, the CRISPR-pioneer-founded epigenetic medicine company known commercially as Epic Bio, renewed its 24,780-square-foot lease at 7000 Shoreline Court in South San Francisco during the first quarter of 2026, according to CBRE's Q1 2026 San […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
Flynn Properties has now bought both 225 Bush St. and Market Center...
ByThe RegistrySeptember 25, 2026Alphabet's robotaxi unit Waymo has signed a letter of intent for roughly...
ByThe RegistrySeptember 25, 2026Hudson Pacific Properties has unloaded its two emptiest San Francisco office holdings...
ByThe RegistrySeptember 25, 2026The two measures on California's November ballot would authorize more than $36...
ByThe RegistrySeptember 25, 2026